Physician profile
Joyce Shea
NPI 1871896357
$4,353.74
in general payments reported to CMS, 2019-2025
35 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what 89% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $865 · 2022: $604 · 2023: $860 · 2024: $896 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,881 · Education: $4.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,881.12 |
| Education | $4.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,016.80 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $482.21 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $331.52 | 2023-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.67 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $223.17 | 2023-2025 | |
| Insulet Corporation | $179.09 | 2023-2025 | Omnipod |
| Pfizer INC. | $172.36 | 2021-2023 | |
| Glaxosmithkline, LLC. | $165.75 | 2021-2023 | Trelegy Ellipta |
| Abbvie INC. | $128.82 | 2021-2023 | |
| Tandem Diabetes Care, INC. | $125.11 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $123.74 | 2024-2025 | Minimed 780g, Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $109.52 | 2021-2023 | Breztri |
| Amarin Pharma, INC. | $108.97 | 2021-2022 | |
| Sequel Med Tech, LLC | $88.19 | 2025 | Twiist |
| Amgen INC. | $82.98 | 2021-2023 | Repatha, Otezla |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.